These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17705297)

  • 41. Autoimmune hepatitis: Single-center experience of clinical presentation, response to treatment and prognosis in Saudi Arabia.
    Fallatah HI; Akbar HO; Qari YA
    Saudi J Gastroenterol; 2010; 16(2):95-9. PubMed ID: 20339178
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Autoimmune paediatric liver disease.
    Mieli-Vergani G; Vergani D
    World J Gastroenterol; 2008 Jun; 14(21):3360-7. PubMed ID: 18528933
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The natural history of autoimmune hepatitis presenting with jaundice.
    Panayi V; Froud OJ; Vine L; Laurent P; Woolson KL; Hunter JG; Madden RG; Miller C; Palmer J; Harris N; Mathew J; Stableforth B; Murray IA; Dalton HR
    Eur J Gastroenterol Hepatol; 2014 Jun; 26(6):640-5. PubMed ID: 24694760
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Usefulness of biochemical remission and transient elastography in monitoring disease course in autoimmune hepatitis.
    Hartl J; Ehlken H; Sebode M; Peiseler M; Krech T; Zenouzi R; von Felden J; Weiler-Normann C; Schramm C; Lohse AW
    J Hepatol; 2018 Apr; 68(4):754-763. PubMed ID: 29180000
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Magnetic resonance elastography is accurate in detecting advanced fibrosis in autoimmune hepatitis.
    Wang J; Malik N; Yin M; Smyrk TC; Czaja AJ; Ehman RL; Venkatesh SK
    World J Gastroenterol; 2017 Feb; 23(5):859-868. PubMed ID: 28223730
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Histologic surveillance after liver transplantation due to autoimmune hepatitis.
    Puustinen L; Boyd S; Arkkila P; Isoniemi H; Arola J; Färkkilä M
    Clin Transplant; 2017 May; 31(5):. PubMed ID: 28235132
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Defining characteristics and long-term prognosis of drug-induced autoimmune-like hepatitis: A retrospective cohort study.
    Chung Y; Morrison M; Zen Y; Heneghan MA
    United European Gastroenterol J; 2024 Feb; 12(1):66-75. PubMed ID: 38041550
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of risk factors for the development of cirrhosis in autoimmune hepatitis: Japanese NHO-AIH prospective study.
    Migita K; Watanabe Y; Jiuchi Y; Nakamura Y; Saito A; Yagura M; Morimoto H; Shimada M; Mita E; Hijioka T; Yamashita H; Takezaki E; Muro T; Sakai H; Nakamuta M; Abiru S; Yano K; Komori A; Yatsuhashi H; Nakamura M; Ishibashi H
    J Gastroenterol; 2011 Jan; 46 Suppl 1():56-62. PubMed ID: 21042923
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Autoimmune hepatitis. Clinical characteristics and response to treatment in a series of 49 spanish patients].
    Bruguera M; Caballería L; Parés A; Rodés J
    Gastroenterol Hepatol; 1998 Oct; 21(8):375-81. PubMed ID: 9844274
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Autoimmune hepatitis-PBC overlap syndrome: a simplified scoring system may assist in the diagnosis.
    Neuhauser M; Bjornsson E; Treeprasertsuk S; Enders F; Silveira M; Talwalkar J; Lindor K
    Am J Gastroenterol; 2010 Feb; 105(2):345-53. PubMed ID: 19888204
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epidemiology and causes of death in a Swedish cohort of patients with autoimmune hepatitis.
    Danielsson Borssén Å; Marschall HU; Bergquist A; Rorsman F; Weiland O; Kechagias S; Nyhlin N; Verbaan H; Nilsson E; Werner M
    Scand J Gastroenterol; 2017 Sep; 52(9):1022-1028. PubMed ID: 28562110
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognosis of acute severe autoimmune hepatitis (AS-AIH): the role of corticosteroids in modifying outcome.
    Yeoman AD; Westbrook RH; Zen Y; Bernal W; Al-Chalabi T; Wendon JA; O'Grady JG; Heneghan MA
    J Hepatol; 2014 Oct; 61(4):876-82. PubMed ID: 24842305
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Type 1 autoimmune hepatitis in Taiwan: diagnosis using the revised criteria of the International Autoimmune Hepatitis Group.
    Koay LB; Lin CY; Tsai SL; Lee C; Lin CN; Sheu MJ; Kuo HT; Sun CS
    Dig Dis Sci; 2006 Nov; 51(11):1978-84. PubMed ID: 17053960
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Natural History and Treatment Outcomes of Severe Autoimmune Hepatitis.
    Sonthalia N; Rathi PM; Jain SS; Surude RG; Mohite AR; Pawar SV; Contractor Q
    J Clin Gastroenterol; 2017 Jul; 51(6):548-556. PubMed ID: 28272079
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New predictive factors of poor response to therapy in autoimmune hepatitis: role of mean platelet volume.
    Abdel-Razik A; Mousa N; Zakaria S; Elhelaly R; Elzehery R; Zalata K; Awad M; Eldeeb AA; Abdelsalam M
    Eur J Gastroenterol Hepatol; 2017 Dec; 29(12):1373-1379. PubMed ID: 29035910
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Autoimmune hepatitis in children: what is different from adult AIH?
    Mieli-Vergani G; Vergani D
    Semin Liver Dis; 2009 Aug; 29(3):297-306. PubMed ID: 19676002
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Difference in clinical presentation, immunology profile and treatment response of type 1 autoimmune hepatitis between United Kingdom and Singapore patients.
    Than NN; Ching DK; Hodson J; McDowell P; Mann J; Gupta R; Salazar E; Ngu JH; Oo YH
    Hepatol Int; 2016 Jul; 10(4):673-9. PubMed ID: 27101826
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characteristics and long-term prognosis of the autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome.
    Lüth S; Kanzler S; Frenzel C; Kasper HU; Dienes HP; Schramm C; Galle PR; Herkel J; Lohse AW
    J Clin Gastroenterol; 2009 Jan; 43(1):75-80. PubMed ID: 18769363
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter Study.
    Efe C; Dhanasekaran R; Lammert C; Ebik B; Higuera-de la Tijera F; Aloman C; Rıza Calışkan A; Peralta M; Gerussi A; Massoumi H; Catana AM; Torgutalp M; Purnak T; Rigamonti C; Gomez Aldana AJ; Khakoo N; Kacmaz H; Nazal L; Frager S; Demir N; Irak K; Ellik ZM; Balaban Y; Atay K; Eren F; Cristoferi L; Batıbay E; Urzua Á; Snijders R; Kıyıcı M; Akyıldız M; Ekin N; Carr RM; Harputluoğlu M; Hatemi I; Mendizabal M; Silva M; Idilman R; Silveira M; Drenth JPH; Assis DN; Björnsson E; Boyer JL; Invernizzi P; Levy C; Schiano TD; Ridruejo E; Wahlin S
    Hepatology; 2021 Jun; 73(6):2099-2109. PubMed ID: 33713486
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1.
    Hino-Arinaga T; Ide T; Kuromatsu R; Miyajima I; Ogata K; Kuwahara R; Hisamochi A; Torimura T; Sata M;
    J Gastroenterol; 2012 May; 47(5):569-76. PubMed ID: 22187167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.